- AU$2.02bn
- AU$1.84bn
- AU$1.10bn
- 89
- 54
- 98
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 32.85 | ||
| PEG Ratio (f) | 0.8 | ||
| EPS Growth (f) | 70.26% | ||
| Dividend Yield (f) | 2.62% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 8.34 | ||
| Price to Sales | 1.68 | ||
| EV to EBITDA | 8.83 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | 9.92% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 744.96 | 752.64 | 787.79 | 844.19 | 1,099.55 | 1,176.58 | 1,271.18 | 11.19% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -81.73 | -33.39 | n/a | n/a | n/a | n/a | +26.19 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Regis Healthcare Limited is an Australia-based aged care operator. The Company provides services to more than 9,000 older Australians through residential aged care homes, home care service hubs, day therapy and day respite centers and retirement villages. Its residential care provides services, including aging-in-place, short stays and respite care, specialist dementia care, and palliative care. It offers a number of aged care service options for short stay, respite care as well as different levels of personal service and choice with its club services, reserve and classic packages to choose from at select homes. Its home care services include provision of services to support older people with complex care needs to live independently in their own homes. It owns and operates specialist retirement and independent living villages in Blackburn South (Victoria), Norwood (Tasmania) and Queensland (Brisbane, Cairns, Townsville, Crows Nest and Atherton).
Directors
- Graham Hodges NEC (66)
- Linda Mellors CEO
- Rick Rostolis CFO
- Rebecca Dean SEC
- Bryan Dorman NED
- Ian Roberts NED
- Christine Bennett NID
- Sally Freeman NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 2nd, 2007
- Public Since
- October 7th, 2014
- No. of Shareholders
- 3,660
- No. of Employees
- 11,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS- Shares in Issue
- 301,249,350
- Address
- Level 2, 615 Dandenong Road, MELBOURNE, 3143
- Web
- https://www.regis.com.au/
- Phone
- +61 300998100
- Auditors
- Ernst & Young
Upcoming Events for REG
Similar to REG
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Careteq
Australian Stock Exchange - SEATS
FAQ
What is the Regis Healthcare share price?
As of Today at 22:53 UTC, shares in Regis Healthcare are trading at AU$6.69. This share price information is delayed by 15 minutes.
How has the Regis Healthcare share price performed this year?
Shares in Regis Healthcare last closed at AU$6.69 and the price had moved by +73.32% over the past 365 days. In terms of relative price strength the Regis Healthcare share price has outperformed the ASX All Ordinaries Index by +70.73% over the past year.
What are the analyst and broker recommendations for Regis Healthcare?
The overall consensus recommendation for Regis Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Regis Healthcare dividend yield?
The Regis Healthcare dividend yield is 2.2% based on the trailing twelve month period.
Does Regis Healthcare pay a dividend?
Last year, Regis Healthcare paid a total dividend of AU$0.15, and it currently has a trailing dividend yield of 2.2%. We do not have any data on when Regis Healthcare is to next pay dividends.
When does Regis Healthcare next pay dividends?
We do not have data on when Regis Healthcare is to next pay dividends. The historic dividend yield on Regis Healthcare shares is currently 2.2%.
How do I buy Regis Healthcare shares?
To buy shares in Regis Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Regis Healthcare?
As of the previous close price of AU$6.69, shares in Regis Healthcare had a market capitalisation of AU$2.02bn.
Where are Regis Healthcare shares listed?
Here are the trading details for Regis Healthcare:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: REG
What kind of share is Regis Healthcare?
Based on an overall assessment of its quality, value and momentum Regis Healthcare is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Regis Healthcare share price forecast for 2025?
The analyst consensus target price for shares in Regis Healthcare is AU$7.61. That is 13.78% above the last closing price of AU$6.69.
Analysts covering Regis Healthcare currently have a consensus Earnings Per Share (EPS) forecast of AU$0.17 for the next financial year.
Find out moreWhat is the trend in the Regis Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Regis Healthcare. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +8.25%.
As of the last closing price of AU$6.69, shares in Regis Healthcare were trading +12.24% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Regis Healthcare PE Ratio?
The Regis Healthcare PE ratio based on its reported earnings over the past 12 months is 32.85. The shares last closed at AU$6.69.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Regis Healthcare?
Regis Healthcare's management team is headed by:
- Graham Hodges - NEC
- Linda Mellors - CEO
- Rick Rostolis - CFO
- Rebecca Dean - SEC
- Bryan Dorman - NED
- Ian Roberts - NED
- Christine Bennett - NID
- Sally Freeman - NID